Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodies

INTRODUCTION: Early diagnosis of systemic sclerosis (SSc) is important to start therapeutic interventions timely. Important risk factors for progression to SSc are the SSc-specific autoantibodies, of whom anti-centromere antibodies (ACA) and anti-topoisomerase I antibodies (ATA) are the most frequen...

Descripción completa

Detalles Bibliográficos
Autores principales: Liem, Sophie I E, Neppelenbroek, Sam, Fehres, Cynthia M, Wevers, Brigitte A, Toes, René E M, Allaart, Cornelia F, Huizinga, Tom W J, Scherer, Hans Ulrich, De Vries-Bouwstra, Jeska K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Systemic Sclerosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906376/
https://www.ncbi.nlm.nih.gov/pubmed/36746531
http://dx.doi.org/10.1136/rmdopen-2022-002827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906376/
https://www.ncbi.nlm.nih.gov/pubmed/36746531
http://dx.doi.org/10.1136/rmdopen-2022-002827

Ejemplares similares